Ablation for atrial fibrillation

A John Camm

doi:10.1038/ncpcardio0603 | Full Text | PDF (75K)

Structural and functional cardiac consequences of obstructive sleep apnea

doi:10.1038/ncpcardio0561 | Full Text | PDF (101K)

New role for MMP-9 in neurovascular remodeling after stroke

doi:10.1038/ncpcardio0562 | Full Text | PDF (87K)

L-arginine therapy following myocardial infarction is ineffective and possibly unsafe

doi:10.1038/ncpcardio0563 | Full Text | PDF (99K)

Preprocedural clopidogrel increases bleeding in off-pump CABG

doi:10.1038/ncpcardio0564 | Full Text | PDF (102K)

Kidney function level can be used to predict survival among patients with CVD

doi:10.1038/ncpcardio0565 | Full Text | PDF (100K)

Warfarin is not appropriate in all patients with AF-associated ischemic stroke

doi:10.1038/ncpcardio0566 | Full Text | PDF (103K)

Lipid-lowering PCSK9 sequence variants protect against coronary heart disease

doi:10.1038/ncpcardio0567 | Full Text | PDF (89K)

Detection of high-risk atherosclerotic plaques by palpography

doi:10.1038/ncpcardio0568 | Full Text | PDF (98K)

Folic acid and B vitamins fail to reduce major cardiovascular risk

doi:10.1038/ncpcardio0569 | Full Text | PDF (101K)

Intensive rosuvastatin therapy leads to regression of atherosclerosis

doi:10.1038/ncpcardio0570 | Full Text | PDF (98K)

Sleep deprivation: a factor in hypertension?

doi:10.1038/ncpcardio0571 | Full Text | PDF (101K)

Infection precipitates venous thromboembolism

doi:10.1038/ncpcardio0572 | Full Text | PDF (97K)

Resolution of migraine headaches after transcatheter closure of patent foramen ovale

doi:10.1038/ncpcardio0573 | Full Text | PDF (100K)

Robotic magnetic navigation for atrial fibrillation ablation is safe and feasible

doi:10.1038/ncpcardio0574 | Full Text | PDF (86K)

Can intensive statin therapy cause regression of coronary atherosclerosis?

David E Newby

doi:10.1038/ncpcardio0604 | Full Text | PDF (100K)

Is facilitated percutaneous coronary intervention superior to primary percutaneous coronary intervention?

Bernard Gersh

doi:10.1038/ncpcardio0586 | Full Text | PDF (97K)

Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients?

Sam Schulman

doi:10.1038/ncpcardio0582 | Full Text | PDF (101K)

Should aprotinin continue to be used during cardiac surgery?

Jerrold H Levy, George J Despotis and Edward Spitznagel

doi:10.1038/ncpcardio0578 | Full Text | PDF (104K)

Can brain natriuretic peptide levels aid diagnosis in children with congenital heart disease?

Douglas S Moodie

doi:10.1038/ncpcardio0605 | Full Text | PDF (96K)

Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?

Serena Tonstad

doi:10.1038/ncpcardio0598 | Full Text | PDF (99K)

Can ACAT inhibition limit the progression of atherosclerosis in patients with coronary artery disease?

Jean-Claude Tardif and Therese Heinonen

doi:10.1038/ncpcardio0599 | Full Text | PDF (98K)

Diastolic ventricular interaction: from physiology to clinical practice

Lynne Williams and Michael Frenneaux

doi:10.1038/ncpcardio0584 | Full Text | PDF (274K)

Drug Insight: clopidogrel nonresponsiveness

Paul A Gurbel and Udaya S Tantry

doi:10.1038/ncpcardio0602 | Full Text | PDF (209K)